Day One Biopharmaceuticals
DAWN
DAWN
45 hedge funds and large institutions have $453M invested in Day One Biopharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.5% more ownership
Funds ownership: 29.33% → 30.83% (+1.5%)
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21.2M | |
| 2 | +$12.3M | |
| 3 | +$4.76M | |
| 4 |
Millennium Management
New York
|
+$4.22M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.6M |
Top Sellers
| 1 | -$6.3M | |
| 2 | -$4.75M | |
| 3 | -$3.57M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$3.08M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$2.58M |